Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19

Reis, Stefanie, Popp, Maria, Kuehn, Rebecca, Metzendorf, Maria-Inti, Gagyor, Ildiko, Kranke, Peter, Meybohm, Patrick, Skoetz, Nicole and Wiebel, Stephanie (2022) 'Nirmatrelvir combined with ritonavir for preventing and treating COVID‐19'. The Cochrane Database of Systematic Reviews, Vol 4, CD015395.

Preview

Text Reis_et_al-2022-Cochrane_Database_of_Systematic_Reviews.pdf - Published Version Download (263kB) | Preview

Abstract

Objectives
This is a protocol for a Cochrane Review (intervention). The objectives are as follows:

To assess the efficacy and safety of nirmatrelvir/ritonavir (Paxlovid®) plus standard of care compared to standard of care with or without placebo, or any other proven intervention for treating COVID‐19 and for preventing SARS‐CoV‐2 infection.

Item Type:	Article
Subjects:	WA Public Health > Preventive Medicine > WA 110 Prevention and control of communicable diseases. Transmission of infectious diseases WC Communicable Diseases > Virus Diseases > Viral Respiratory Tract Infections. Respirovirus Infections > WC 506 COVID-19
Faculty: Department:	Clinical Sciences & International Health > Clinical Sciences Department
Digital Object Identifer (DOI):	https://doi.org/10.1002/14651858.cd015395
Depositing User:	Christianne Esparza
Date Deposited:	19 May 2022 14:17
Last Modified:	11 Apr 2023 01:02
URI:	https://archive.lstmed.ac.uk/id/eprint/20419

Statistics

View details

Actions (login required)

Edit Item